tradingkey.logo

Immunoprecise Antibodies Ltd

IPA
View Detailed Chart

1.640USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
75.69MMarket Cap
LossP/E TTM

Immunoprecise Antibodies Ltd

1.640

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.20%

5 Days

-24.07%

1 Month

+25.19%

6 Months

+271.88%

Year to Date

+298.35%

1 Year

+90.70%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
4.000
Target Price
143.90%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

173
Total
5
Median
8
Average
Company name
Ratings
Analysts
Immunoprecise Antibodies Ltd
IPA
2
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
34
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
35

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(2)
Buy(4)
Indicators
Sell(2)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.127
Neutral
RSI(14)
51.143
Neutral
STOCH(KDJ)(9,3,3)
14.964
Sell
ATR(14)
0.260
Low Volatility
CCI(14)
-109.117
Sell
Williams %R
86.517
Oversold
TRIX(12,20)
2.105
Buy
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
1.757
Sell
MA10
1.852
Sell
MA20
1.809
Sell
MA50
1.195
Buy
MA100
0.813
Buy
MA200
0.633
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Ticker SymbolIPA
CompanyImmunoprecise Antibodies Ltd
CEODr. Jennifer Lynne Bath, Ph.D.
Websitehttps://www.ipatherapeutics.com/
KeyAI